Authors: IWATA N PUCHLER K PLENKER A

Citation: N. Iwata et al., PHARMACOLOGY OF THE NEW REVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE-A, RS-8359, International clinical psychopharmacology, 12, 1997, pp. 3-10

Authors: PUCHLER K SASAHARA K PLENKER A NITANAI T WITTE PU

Citation: K. Puchler et al., THE PHARMACOKINETIC PROFILE OF RS-8359, International clinical psychopharmacology, 12, 1997, pp. 11-16

Authors: PUCHLER K SCHAFFLER K PLENKER A

Citation: K. Puchler et al., THE COMPARATIVE EFFECTS OF SINGLE AND MULTIPLE DOSES OF RS-8359, MOCLOBEMIDE AND PLACEBO ON PSYCHOMOTOR FUNCTION IN HEALTHY-SUBJECTS, International clinical psychopharmacology, 12, 1997, pp. 17-23

Authors: PLENKER A PUCHLER K VOLZ HP

Citation: A. Plenker et al., THE EFFECTS OF RS-8359 ON CARDIOVASCULAR FUNCTION IN HEALTHY-SUBJECTSAND DEPRESSED-PATIENTS, International clinical psychopharmacology, 12, 1997, pp. 25-29

Authors: PUCHLER K PLENKER A VOLZ HP

Citation: K. Puchler et al., SAFETY, TOLERABILITY AND EFFICACY OF THE REVERSIBLE MONOAMINE-OXIDASEINHIBITOR RS-8359 IN EARLY CLINICAL-TRIALS, International clinical psychopharmacology, 12, 1997, pp. 31-36

Authors: PUCHLER K SASAHARA K LAEIS P PLENKER A

Citation: K. Puchler et al., PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF TROGLITAZONE IN NIDDM PATIENTS WITH GLIBENCLAMIDE, Diabetologia, 40, 1997, pp. 1233-1233